Masters degree in Life sciences / MPharm/ MVSc from a recognized university or equivalent. Candidate with One year experience in mammalian cell culture / biomaterials / molecular biology / animal handling will be given preference.
PG in Life Sciences / Biology or an associated field, possesses National Eligibility Tests- CSIR UGC NET including Lectureship and GATE certificate or qualified National Level examination conducted by Central Government departments/agencies /institutions
B.Pharm or Equivalent from recognized Institution. The Blinatumomab Project has been envisioned as a multicentric project which facilitates treatment for relapsed or refractory B-cell precursor acute lymphoblastic leukaemia in adults and children.
Postgraduate degree in Life Sciences / Biology or an associated field, possesses National Eligibility Tests- CSIR UGC NET including Lectureship and GATE certificate or qualified National Level examination conducted by Central Government departments
Graduate Degree in Biotechnology or any Life Sciences subject from a recognized University or equivalent. Understanding the Molecular Mechanism in Ceramide Induced Pathological Activation of Nek7/Nlrp3-Inflammasome.
Bachelor of Science (B.Sc) with biology as main subject, Bachelors in Engineering with biotechnology (MSc) with minimum 55% of total marks (equivalent grade) in Molecular biology, Genetics, Biochemistry, Biotechnology.